These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7956610)

  • 21. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis.
    Nilsson HO; Taneera J; Castedal M; Glatz E; Olsson R; Wadström T
    J Clin Microbiol; 2000 Mar; 38(3):1072-6. PubMed ID: 10698999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting.
    Bosch DE; Zen Y; Boukhar SA; Liu Y; Cheng L; Yeh MM
    Virchows Arch; 2021 Dec; 479(6):1131-1143. PubMed ID: 34414507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis.
    Alvaro D; Invernizzi P; Onori P; Franchitto A; De Santis A; Crosignani A; Sferra R; Ginanni-Corradini S; Mancino MG; Maggioni M; Attili AF; Podda M; Gaudio E
    J Hepatol; 2004 Dec; 41(6):905-12. PubMed ID: 15645536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomic analysis of cholestatic liver damage in mice.
    Yang R; Zhao Q; Hu DD; Xiao XR; Huang JF; Li F
    Food Chem Toxicol; 2018 Oct; 120():253-260. PubMed ID: 30009888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR.
    Wunsch E; Klak M; Wasik U; Milkiewicz M; Blatkiewicz M; Urasinska E; Barbier O; Bielicki D; Bogdanos DP; Elias E; Milkiewicz P
    J Immunol Res; 2015; 2015():571353. PubMed ID: 26504856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cholestatic liver diseases].
    Grimm D; Thimme R
    Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
    Bedlow AJ; Donaldson PT; McFarlane BM; Lombard M; McFarlane IG; Williams R
    J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients.
    Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M
    Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased Expression of Vitamin D Receptor Affects an Immune Response in Primary Biliary Cholangitis via the VDR-miRNA155-SOCS1 Pathway.
    Kempinska-Podhorodecka A; Milkiewicz M; Wasik U; Ligocka J; Zawadzki M; Krawczyk M; Milkiewicz P
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.
    Mendes FD; Jorgensen R; Keach J; Katzmann JA; Smyrk T; Donlinger J; Chari S; Lindor KD
    Am J Gastroenterol; 2006 Sep; 101(9):2070-5. PubMed ID: 16879434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased in vitro production of tumor necrosis factor in primary biliary cirrhosis patients.
    Broomé U; Eriksson LS; Sundin U; Sundqvist KG
    Scand J Gastroenterol; 1992; 27(2):124-8. PubMed ID: 1561525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective evaluation of the diagnostic accuracy of hepatic copper content, as determined using the entire core of a liver biopsy sample.
    Yang X; Tang XP; Zhang YH; Luo KZ; Jiang YF; Luo HY; Lei JH; Wang WL; Li MM; Chen HC; Deng SL; Lai LY; Liang J; Zhang M; Tian Y; Xu Y
    Hepatology; 2015 Dec; 62(6):1731-41. PubMed ID: 26095812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Hegade VS; Jones DE; Hirschfield GM
    Dig Dis; 2017; 35(3):267-274. PubMed ID: 28249258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which patients with primary biliary cirrhosis or primary sclerosing cholangitis should undergo endoscopic screening for oesophageal varices detection?
    Bressler B; Pinto R; El-Ashry D; Heathcote EJ
    Gut; 2005 Mar; 54(3):407-10. PubMed ID: 15710991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis.
    Hashimoto E; Lindor KD; Homburger HA; Dickson ER; Czaja AJ; Wiesner RH; Ludwig J
    Mayo Clin Proc; 1993 Nov; 68(11):1049-55. PubMed ID: 8231268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases.
    Wunsch E; Krawczyk M; Milkiewicz M; Trottier J; Barbier O; Neurath MF; Lammert F; Kremer AE; Milkiewicz P
    Sci Rep; 2016 Aug; 6():30847. PubMed ID: 27506882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.
    Jazrawi RP; de Caestecker JS; Goggin PM; Britten AJ; Joseph AE; Maxwell JD; Northfield TC
    Gastroenterology; 1994 Jan; 106(1):134-42. PubMed ID: 8276175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keratin 7 expression in hepatic cholestatic diseases.
    Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
    Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation of macrophages in primary sclerosing cholangitis.
    Cameron RG; Blendis LM; Neuman MG
    Clin Biochem; 2001 May; 34(3):195-201. PubMed ID: 11408017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis.
    Raszeja-Wyszomirska J; Wunsch E; Krawczyk M; Rigopoulou EI; Bogdanos D; Milkiewicz P
    Liver Int; 2015 Jun; 35(6):1764-71. PubMed ID: 25388280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.